Technical milestones
Caporaso and colleagues sampled three body habitats (stool, mouth and palms) from two subjects daily for 6 or 15 months, collecting hundreds of densely spaced specimens. To analyze these specimens, they used Illumina sequencing (Illumina, Inc., San Diego, CA, USA) to reduce cost and increase throughput and depth of sampling [9] , and the Amazon Elastic Compute Cloud (Amazon EC2 [10] ) for low cost, high bandwidth computational resources. Both of these methodologies offer the prospect of moving future metagenomic studies from the limited sampling realm to the dense sampling that may be required to decipher the patterns of the microbiome.
is experimental design moves the bottleneck upstream to the sampling phase. Taking full advantage of this increased data production and computation requires more samples, and this introduces its own cost and logistics challenges.
As another technical sideline of the study, the data were a combination of sequences from different regions of the 16S rRNA gene, produced with different sequencing platforms: legacy data from 454 sequencing mixed with the Illumina 16S rRNA sequences. Sufficient concordance was observed between the data sets to allow the study to use the merged collection.
ere has been a prevailing concern that different sequencing methods, read lengths and variable regions within 16S rRNA perform differently in terms of the taxa they detect, so this result is of high interest for those who wish to combine data sets to increase the power of studies but are concerned about introducing biases or other confounding factors for the analysis.
Waxing and waning taxa
e picture of the microbiome that emerges from the study of Caporaso and colleagues is one of volatility. At each body site, there are relatively few taxa that are present throughout the entire sampling period. Rather, most taxa are classified as either persistent, being detectable in many consecutive samplings before disappearing, or transient, being found for only short periods of time. One has the image of the persistent organisms blooming to high numbers, only to retreat until they bloom again. All of this is amidst a flux of short-term visitors to the community.
Another interesting characteristic is that taxa within persistent and transient categories can be different, allow ing these communities to be distinguished. In the two subjects studied, the stool microbiomes of both persistent and transient communities had few predominant taxa: the Clostridia, Bacteroidia and, in one subject, Erysipelotrichi. However, the persistent and transient communities in both subjects could be differentiated by the presence of Betaproteobacteria and Deltaproteobacteria in persistent communities, while transient communities uniquely contained Gammaproteobacteria and Bacilli. In one subject, Actinobacteria, Epsilonproteobacteria and Verrucomicrobia were also unique to the transient community. The tongue and palms had many more predominant taxonomic classes, but none of these taxa clearly differentiated persistent and transient communities consistently across the two subjects.
Despite this mercurial community structure, the communities of the three different habitats remain distinguishable from each other at all times. This suggests that the players in each community, and the bounds on their abundances and half-lives, are some of the differentiating characteristics of each body habitat.
Defining disease microbiomes
It is notable that despite enormous interest and activity in human microbiome research, no associations between a disease and microbial community have been shown. Perhaps this will change once temporal variability is taken into account in experimental design and analysis. Caporaso et al. [8] move the field closer to being able to discern associations between microbiome structure and clinical phenotype by showing that the degree of variation over time is significant. It seems likely that this variation may provide a noise level that could obscure correlations. This does introduce a new challenge: how to analyze such temporally variable data to find robust relationships. Perhaps from this study, or future ones building on it, the number of specimens, depth of sampling, and frequency and duration of sampling needed to improve experimental designs can be deduced.
One of the hopes for making such an association is to produce new diagnostic approaches for microbiome-related conditions. However, if long-term time series are required for these diagnoses, it will limit their utility. One hopes that within this volatile microbiome there are still unique and less variable elements to be discovered, and that these can be of use for more immediate diagnostic or therapeutic techniques.
